Neurocrine Biosciences
Price & Volume
Stats
See more52W Range | $84.23-$154.61 |
Market Cap | $13.5B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $2.5B |
Revenue Growth (YoY) | 16.5% |
Gross Profit (12 Mos) | $1.5B |
Diluted EPS | $3.38 |
News
See moreYahoo Finance • 2 days ago
Goldman says these 20 overlooked stocks are poised to spike this coming earnings season
Yahoo Finance • 6 days ago
Sector Update: Health Care Stocks Retreat Late Afternoon
Yahoo Finance • 6 days ago
Advanced Viral Delivery Systems Revolutionizing Gene Therapy for Neurological Disorders
Yahoo Finance • 10 days ago
Nanobiotix gains after early-stage trial data for J&J-partnered cancer drug
About
CEO | Mr. Kyle W. Gano Ph.D. |
Address | 12780 El Camino Real, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,800 |
